📖 Approx. 4 minutes / Updated 2026.06.28
This article explains the key considerations for Regional Medical Collaboration Promotion Corporations in business succession and medical M&A involving tax schemes, from the practical perspective of an M&A advisor specializing in the healthcare industry. We will provide concrete strategies focusing on optimizing capital gains tax, inheritance tax, and gift tax, as well as their utilization as an alternative to M&A.
1. Industry Background of Tax Schemes for Regional Medical Collaboration Promotion Corporations
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the management environment for medical institutions, including tax schemes, has become increasingly challenging in recent years due to a combination of factors such as medical fee revisions, rising labor costs, and the burden of capital investment. Interest in third-party succession M&A is growing, particularly from the perspective of optimizing capital gains tax, inheritance tax, and gift tax.
At the same time, Regional Medical Collaboration Promotion Corporations are an important consideration in medical M&A practice. By appropriately designing their utilization as an alternative to M&A, succession that benefits both the seller and the buyer can be achieved.
2. Key Practical Points
- Preparation: Organize the specific workflow, patient base, and facility status related to the tax scheme and clarify the terms of transfer.
- Business Valuation: Calculate an appropriate transfer price range based on the characteristics of the medical specialty. For tax schemes, optimizing capital gains tax, inheritance tax, and gift tax is key to the valuation.
- Design of the Regional Medical Collaboration Promotion Corporation: Select the optimal scheme, considering its use as an alternative to M&A. Verification from tax, legal, and labor perspectives is also necessary.
- Target Search and Matching: Select potential buyers nationwide that match the characteristics of the medical specialty. Proceed carefully with aligning desired conditions.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Also, confirm licenses and facility standards specific to the tax scheme.
- Final Agreement and Closing: Execute the final agreement, including representations and warranties, and indemnification clauses. Simultaneously proceed with the transfer of licenses and staff communication.
3. Specific Points of Caution in Tax Schemes
In medical institution M&A involving tax schemes, the optimization of capital gains tax, inheritance tax, and gift tax is the key to successful succession. Numerous individual issues exist depending on the characteristics of the medical specialty, such as the continuity of the patient base, employment retention of staff (doctors, nurses, paramedical staff), the condition and renewal plan of facilities, and the maintenance and acquisition of facility standards.
Furthermore, strategic design that considers the market characteristics unique to tax schemes is important, including the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with neighboring competing medical institutions. Leveraging our experience in supporting succession through tax schemes, we provide practical support from an industry-specialized perspective.
4. Detailed Practical Aspects of Regional Medical Collaboration Promotion Corporations
Regional Medical Collaboration Promotion Corporations are an area requiring specialized consideration in medical M&A. Designing them with their utilization as an alternative to M&A in mind is key to success.
- Confirmation of Relevant Laws and Practical Standards: Compliance with the Medical Care Act, tax laws, and labor laws.
- Collaboration with Experts: Cooperation with certified public accountants, tax accountants, lawyers, and labor consultants.
- Risk Assessment: Identification of potential risks and development of countermeasures.
- Consensus Building Among Parties: Designing terms that provide satisfaction for both the seller and the buyer.
- Appropriate Documentation: Explicitly stated in the letter of intent and final agreement.
Frequently Asked Questions
Q. What documents are required for consultation?
A. Please prepare financial statements for the last three fiscal years, patient number trends, staff composition, facility lists, and lease agreements (if applicable) in advance for a smoother process. We will receive them after signing an NDA.
Q. What is the market price range for transfers under a tax scheme?
A. For tax schemes, the optimization of capital gains tax, inheritance tax, and gift tax serves as the evaluation criterion. The benchmark is 0.5 to 1.5 times annual sales for non-bed facilities, and 3 to 7 times EBITDA for bedded facilities and hospitals. Detailed information will be provided through a free preliminary assessment.
Q. What are the points to consider when proceeding with a Regional Medical Collaboration Promotion Corporation?
A. Preliminary design considering its use as an alternative to M&A is essential. Successful execution requires collaboration with experts to ensure no details are missed.
Q. Will my consultation be known to staff or patients?
A. Information is disclosed on a limited basis after signing an NDA, and disclosure to related parties before the final agreement is not made. Confidentiality is strictly maintained.
Related Columns
- Complete Guide to Business Succession for Hospitals and Medical Corporations | From Successor Shortages to Success Stories, Practical Aspects of Medical M&A
- Complete Guide to Selling or Transferring a Clinic | Medical M&A Experts Explain Market Prices, Procedures, and Points to Consider
- How to Proceed with Medical M&A and Hospital Succession | Explaining the 6 Steps from Consultation to Closing with Real Examples
- Complete Guide to Tax Schemes in Medical Corporation M&A | Points to Note for Tax Accountants and CPAs
Consultations on Tax Schemes for Regional Medical Collaboration Promotion Corporations with M&A Medical
Strict Confidentiality, Free Initial Consultation, Success-Based Fee